Literature DB >> 16698327

A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients.

Sivia De Francia1, Elisa Pirro, Franco Zappia, Francesca De Martino, Andrea Elio Sprio, Fulvia Daffara, Massimo Terzolo, Alfredo Berruti, Francesco Di Carlo, Franco Ghezzo.   

Abstract

A new C18 reversed-phase column and UV HPLC method for the detection of mitotane, its principal metabolites, dichlorodiphenylacetate and dichlrodiphenylethene, and its precursor DDT is described. In this article mitotane, dichlorodiphenylacetate, and dichlrodiphenylethene concentrations in organs of rats fed on a mitotane diet, and the effects of erythromycin and grapefruit juice as cytochrome P450 common inhibitors are presented. Tissue accumulation of mitotane and dichlrodiphenylethene, the acquired ability to eliminate dichlorodiphenylacetate, and inhibition of beta-hydroxylation by both inhibitors are illustrated here. Blood samples from mitotane-treated patients revealed two correlations: plasma mitotane/dichlrodiphenylethene and plasma mitotane/red cell mitotane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698327     DOI: 10.1016/j.jchromb.2006.04.005

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells.

Authors:  Antonina Germano; Laura Saba; Silvia De Francia; Ida Rapa; Paola Perotti; Alfredo Berruti; Marco Volante; Massimo Terzolo
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

2.  Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study.

Authors:  Barbara Altieri; Silviu Sbiera; Sabine Herterich; Silvia De Francia; Silvia Della Casa; Anna Calabrese; Alfredo Pontecorvi; Marcus Quinkler; Tina Kienitz; Massimo Mannelli; Letizia Canu; Anna Angelousi; Vasileios Chortis; Matthias Kroiss; Massimo Terzolo; Martin Fassnacht; Cristina L Ronchi
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

3.  Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma.

Authors:  Sarah Allegra; Soraya Puglisi; Chiara Borin; Francesco Chiara; Vittoria Basile; Anna Calabrese; Giuseppe Reimondo; Silvia De Francia
Journal:  Biomedicines       Date:  2022-08-03

4.  A simplified method for therapeutic drug monitoring of mitotane by gas chromatography-electron ionization-mass spectrometry.

Authors:  Motozumi Ando; Masaki Hirabatake; Hisateru Yasui; Shoji Fukushima; Nobuyuki Sugioka; Tohru Hashida
Journal:  Biomed Chromatogr       Date:  2020-01-28       Impact factor: 1.902

5.  Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma.

Authors:  Sarah Allegra; Soraya Puglisi; Irene Brescia; Francesco Chiara; Vittoria Basile; Anna Calabrese; Giuseppe Reimondo; Silvia De Francia
Journal:  Life (Basel)       Date:  2021-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.